Oxyquinoline

Oxyquinoline

SCHEMBL29358129

O=S(=O)(O)O.Oc1cccc2cccnc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO

The experimentally established mechanism targets of Oxyquinoline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.81
ADRA1A known ✓ P35348 1/20 0.81
KDM4E B2RXH2 4/20 1.00
ALOX12 P18054 2/20 1.00
COMT P21964 3/20 0.81
MMP2 P08253 2/20 0.81
TSHR P16473 2/20 0.81
METAP2 P50579 1/20 0.81
METAP1 P53582 1/20 0.81
HDAC8 Q9BY41 1/20 0.81
LMNA P02545 3/20 0.63
ALDH1A1 P00352 3/20 0.63
MAPK1 P28482 2/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA9 Q16790 1/20 0.58
TDP1 Q9NUW8 3/20 0.55
GAA P10253 3/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxyquinoline SCHEMBL11030481 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL29390000 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL11030474 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL9625423 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL48928 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL29598375 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL324753 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL11030477 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL406261 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL6081972 0.98 KDM4E (0.96) KDM4EALOX12COMTMMP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120130470-A Processing method for quick dyeing and fresh-keeping cooperative treatment of cut flowers of starfish and special preparation 云南花益美生物科技有限责任公司 2025-06-13 CN claimed
CN-119949225-A Method for promoting flowers of cut flowers of starfish after picking 云南花益美生物科技有限责任公司 2025-05-09 CN claimed
US-20250057877-A1 MULTIPLE USE WOUND AND HEALING CREAM COLEMAN TERRIS VIOLA (US) 2025-02-20 US claimed
CN-118435802-A Method for prolonging ornamental period of cut peony flowers 甘肃省农业科学院林果花卉研究所 2024-08-06 CN claimed
CN-115152455-B Method for producing cut lotus flowers 苏州市农业科学院 2023-09-22 CN claimed
CN-122011884-A Self-repairing/corrosion early warning dual-functional coating based on corrosion cathode micro-area environment response release 西南交通大学 2026-05-12 CN disclosed
EP-4676925-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS Syngenta Crop Protection AG (CH) 2026-01-14 EP disclosed
US-20250388630-A1 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA SPOGEN BIOTECH INC (US) 2025-12-25 US disclosed
EP-4655284-A1 MICROBIOCIDAL PYRAZOLE DERIVATIVES Syngenta Crop Protection AG (CH) 2025-12-03 EP disclosed
CN-120982502-A High-openness starfish cut flower anti-aging pretreatment liquid based on water-energy-ethylene synergistic regulation and control and negative pressure permeation treatment method thereof 云南花益美生物科技有限责任公司 2025-11-21 CN disclosed
WO-2025235840-A1 ECHINOCANDIN-LIKE AND BORON-CONTAINING ECHINOCANDIN COMPOUNDS AND THEIR USE AS AGROCHEMICAL FUNGICIDES 5METIS, INC. (US) 2025-11-13 WO disclosed
EP-4646403-A1 NOVEL CARBOXAMIDE AND SULFONAMIDE PESTICIDAL COMPOUNDS Syngenta Crop Protection AG (CH) 2025-11-12 EP disclosed
CN-113749088-B Peony cut flower vase preservative solution 北京林业大学 2022-04-29 CN disclosed
WO-2022053567-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA CROP PROTECTION AG (CH) 2022-03-17 WO disclosed
WO-2022049498-A1 FORMULATIONS AND METHODS FOR REGULATING AND STIMULATING PLANT GROWTH UPL LIMITED (IN) 2022-03-10 WO disclosed
WO-2022048988-A1 PLANT GROWTH REGULATOR COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2022-03-10 WO disclosed
WO-2022043576-A2 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA CROP PROTECTION AG (CH) 2022-03-03 WO disclosed
EP-3952652-A1 FUNGICIDAL COMPOSITIONS Syngenta Crop Protection AG (CH) 2022-02-16 EP disclosed
EP-3945824-A1 COLLOIDAL SILVER-BASED COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTING AND CONTROLLING PLANT DISEASES Clearleaf Inc. (US) 2022-02-09 EP disclosed
WO-2022017975-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA CROP PROTECTION AG (CH) 2022-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388630-A1 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA MAX, SEC62, GHITM CHRM1 4831/4885ADRA1A 4874/4885KDM4E 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.